Serving as a senior technology or life science executive for over 20 years—as either the CEO or Vice President with overall P&L authority for companies or functional teams of up to 65 people, Dennis has been instrumental in introducing new technologies and services. His background and qualifications laid the foundation for creation of a company focused on the design and deployment of a digital health platform.
In order to utilize the latest digital health and cloud technologies to advance the science of medication adherence, Dennis understands the importance of building a cohesive team with the unique skills and qualifications that computer scientists, medical device hardware professionals, clinical workflow experts, usability specialists and healthcare advocates bring to the table. Only by utilizing a multi-disciplinary team can an innovative solution be accurately tested and validated.
Dennis has the technical and management experience/skills most necessary to lead a talented team of technology professionals. His background in healthcare integration of technology into clinical workflows uniquely qualifies him to shape and lead the development and growth of Curadite’s Medication Management Platform. As a driven innovator and visionary, Dennis is able to rapidly assess new customers, draw out hidden agendas, distinguish between “must have” and “would like to have” and lead the design and implementation of innovative solutions that delight and amaze customers. Dennis founded three companies that were merged/acquired, one of which provided a 17x return on investment.
Hosts Karl Ulrich and Rob Coneybeer are joined by Scot Land (President and Co-Founder, Alitheon), Larissa Rocha (Chief Community Officer, Brex), and Dennis McNannay (CEO, Curadite, Inc. ) on the Wednesday, October 9, 2019 edition of Launch Pad.